Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies

Despite a strong preclinical rationale for targeting the insulin-like growth factor (IGF) axis in cancer, clinical studies of IGF-1 receptor (IGF-1R)-targeted monotherapies have been largely disappointing, and any potential success has been limited by the lack of validated predictive biomarkers for...

Descripción completa

Detalles Bibliográficos
Autores principales: Simpson, Aaron, Petnga, Wilfride, Macaulay, Valentine M., Weyer-Czernilofsky, Ulrike, Bogenrieder, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610669/
https://www.ncbi.nlm.nih.gov/pubmed/28815409
http://dx.doi.org/10.1007/s11523-017-0514-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610669/
https://www.ncbi.nlm.nih.gov/pubmed/28815409
http://dx.doi.org/10.1007/s11523-017-0514-5

Ejemplares similares